Recipharm has established a dedicated taskforce to manage the potential impact of Brexit on its organization. The UK will exit the European Union (EU) as of March 30, 2019. Recipharm, headquartered in Sweden, is focused on managing the transition with minimal impact to its operations and customers. The Brexit taskforce will prioritize its preparations and invest in the necessary capabilities and equipment within its UK and European facilities to ensure seamless operations post March 2019. The...